DelveInsight launched a new report on Osteosarcoma Epidemiology Forecast, 2030.
Osteosarcoma (also called osteogenic sarcoma) is the most common type of cancer that starts in the bones. The cancer cells in these tumors look like early forms of bone cells that normally help make new bone tissue, but the bone tissue in Osteosarcoma is not as strong as that of normal bones
DelveInsight’s ‘Osteosarcoma Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Osteosarcoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key highlights from the Osteosarcoma Epidemiology Report:
As per DelveInsight analysts, the total incident population of osteosarcoma in the 7MM was 2,228 in 2020.
The estimates show the highest incident cases of osteosarcoma in the United States with 1,174 cases in 2020.
In 2020, out of the total incident population of 1,174 cases in the US, 620 and 554 cases were contributed by males and females, respectively.
In 2020, age groups 0–24 years, 25–59 years, and >60 years accounted for 532, 297, and 345 cases, respectively, in the United States.
Visit for more @ Osteosarcoma Epidemiology Insights
Scope of the Osteosarcoma Epidemiology report:
The Osteosarcoma report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
The Osteosarcoma Epidemiology Report and Model provide an overview of the risk factors and global trends of Osteosarcoma in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
The report provides insight into the historical and forecasted patient pool of Osteosarcoma in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
The report helps to recognize the growth opportunities in the 7MM concerning the patient population
The report assesses the disease risk and burden and highlights the unmet needs of Osteosarcoma
The report provides the segmentation of the Osteosarcoma epidemiology
Table of Contents:
1. Key Insights
2. Executive Summary of Osteosarcoma
3. Osteosarcoma Epidemiology Overview at a Glance
4. Osteosarcoma: Disease Background and Overview
5. Epidemiology and Patient Population
6. Case Reports
7. Country Wise-Epidemiology of Osteosarcoma
9. DelveInsight Capabilities
11. About DelveInsight
DelveInsight’s ‘Osteosarcoma-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
“Osteosarcoma Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Osteosarcoma market. A detailed picture of the Osteosarcoma pipeline landscape is provided, which includes the disease overview and Osteosarcoma treatment guidelines.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States